October 19, 2017 6:40 PM ET

Healthcare Providers and Services

Company Overview of Aurora Diagnostics, LLC

Company Overview

Aurora Diagnostics, LLC, a specialized laboratory company, provides unsurpassed diagnostic, prognostic, and therapeutic information and services to physicians, hospital systems, and researchers in the United States. It offers pathology services, such as dermatopathology, gastrointestinal and hepatic pathology, hematopathology, and genitourinary; and pathology services to women’s health care providerpathology. The company also provides molecular diagnostic services that focus on pharmacogenomics, oncology, women’s health, and infectious diseases; and hospital-based clinical and management solutions, such as anatomic and clinical, professional component, and technical component pathology servi...

11025 RCA Center Drive

Suite 300

Palm Beach Gardens, FL 33410

United States

Founded in 2006

1,102 Employees

Phone:

866-420-5512

Fax:

561-626-4530

Key Executives for Aurora Diagnostics, LLC

Chief Executive Officer and President
Age: 69
Executive Vice President of Sales & Marketing
Age: 47
Compensation as of Fiscal Year 2017.

Aurora Diagnostics, LLC Key Developments

Aurora Diagnostics Enters into a Seventh Amendment to Financing Agreement

On April 20, 2017, Aurora Diagnostics Holdings, LLC, as guarantor, its subsidiary Aurora Diagnostics, LLC, as borrower, and certain other subsidiaries of the Company, as guarantors, entered into a seventh amendment to the Financing Agreement, dated as of July 31, 2014 with Cerberus Business Finance, LLC, as administrative agent and collateral agent. The Seventh Amendment amended the definition of Final Maturity Date to modify the provision that accelerated the maturity date of the Financing Agreement to October 14, 2017 in the event that any of the Company's 10.750% Senior Notes due 2018 had not been refinanced prior to such date. As amended, the maturity of the Financing Agreement will be accelerated to October 14, 2017 only in the event that the maturity of more than $2.6 million in aggregate principal amount of Existing Notes has not been extended to October 31, 2019 or a later date on or before October 14, 2017. In addition, pursuant to the Seventh Amendment, the lenders thereunder consented to the Company redeeming, repurchasing or paying at maturity up to $2.6 million of Existing Notes at any time and from time to time within eight months of the consummation of the Company's Exchange Offer.

Aurora Diagnostics Holdings, LLC and Aurora Diagnostics, LLC Enters into Sixth Amendment to the Financing Agreement

On March 27, 2017, Aurora Diagnostics Holdings, LLC (the Company"), its subsidiary Aurora Diagnostics, LLC, as borrower, and certain other subsidiaries of the Company, as guarantors, entered into a sixth amendment to the Financing Agreement, dated as of July 31, 2014 (as amended, restated, supplemented or otherwise modified from time to time, the Financing Agreement") with Cerberus Business Finance, LLC, as administrative agent and collateral agent. The sixth amendment amends the definition of Permitted Acquisition" under the Financing Agreement to permit the company to consummate certain additional acquisitions upon the payment of a $225,000 consent fee. The sixth amendment provides a 60 day extension to the Company's obligation to deliver its audited financial statements for the year ended December 31, 2016 pursuant to the Financing Agreement. In connection with the extension, the sixth amendment provides that, beginning on April 1, 2017 until the date on which the financial statements have been delivered, the Applicable Margin shall increase to 7.125%, in the case of Reference Rate Loans, and 8.125%, in the case of LIBOR Rate Loans. The company intends to deliver its audited financial statements for the year ended December 31, 2016 on March 31, 2017, and therefore, does not expect an increase in the Applicable Margin.

Similar Private Companies By Industry

Company Name Region
@ Home Medical, Inc. United States
@home approach, llc United States
@Home Care United States
1011 E. Pecan Grove Road, LLC United States
1104 Welsh Road Operations LLC United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
May 15, 2017
Cleveland Skin Pathology Laboratory Inc.
Merger/Acquisition
April 18, 2017
Pathology Associates of Princeton
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Aurora Diagnostics, LLC, please visit www.auroradx.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.